Health Blueprint

Back to Longevity News

News summary

DMC Secures $18M to Expand Health Ingredients Business — Sofinnova Partners

Source: Sofinnova Partners • Published: 26 Oct 2026, 00:00

Summarized by Masters of Longevity from Sofinnova Partners.

DMC secured $18 million to commercialize KeyPura bioactives.

DMC Secures $18M to Expand Health Ingredients Business — Sofinnova Partners
Key Takeaways
  • DMC raised $18 million to accelerate KeyPura commercialization.
  • KeyPura is composed of myo‑inositol and D‑chiro‑inositol.
  • The funding will expand adoption and advance new bioactives.
Read the full article at Sofinnova Partners ↗

Continue exploring

Recommended MoL Picks

MoL PickApple Brings Longevity to the Wrist. What Will It Change?Apple’s new Health Age, readiness and movement tools bring long-term health into everyday view. The opportunity is turning that information into useful action.MoL PickMOTS-c: Where the Evidence EndsStudies offer clues about ageing and metabolism. What do they actually tell us about human health—and where does expert opinion take over?MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.